TSVT
Price:
$3.61
Market Cap:
$185.91M
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2021-11-03
Stock Exchange
NASDAQ
Ticker
TSVT
According to 2seventy bio, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 373.37M. This represents a change of -11.31% compared to the average of 420.98M of the last 4 quarters.
The mean historical Enterprise Value of 2seventy bio, Inc. over the last ten years is 474.19M. The current 373.37M Enterprise Value has changed 7.77% with respect to the historical average. Over the past ten years (40 quarters), TSVT's Enterprise Value was at its highest in in the December 2021 quarter at 756.29M. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.
Average
474.19M
Median
554.47M
Minimum
0
Maximum
756.28M
Discovering the peaks and valleys of 2seventy bio, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = Infinity%
Maximum Annual Enterprise Value = 756.28M
Minimum Annual Increase = -29.52%
Minimum Annual Enterprise Value = 0
Year | Enterprise Value | Change |
---|---|---|
2023 | 392.12M | -26.44% |
2022 | 533.06M | -29.52% |
2021 | 756.28M | 31.33% |
2020 | 575.87M | -2.03% |
2019 | 587.82M | Infinity% |
The current Enterprise Value of 2seventy bio, Inc. (TSVT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
560.49M
5-year avg
569.03M
10-year avg
474.19M
2seventy bio, Inc.’s Enterprise Value is less than Intercept Pharmaceuticals, Inc. (915.81M), greater than Puma Biotechnology, Inc. (166.37M), less than Iovance Biotherapeutics, Inc. (2.52B), less than Sarepta Therapeutics, Inc. (12.11B), less than Day One Biopharmaceuticals, Inc. (963.46M), greater than Inozyme Pharma, Inc. (202.73M), greater than Zentalis Pharmaceuticals, Inc. (229.32M), less than Syndax Pharmaceuticals, Inc. (1.24B), less than Protagonist Therapeutics, Inc. (2.65B), greater than Theseus Pharmaceuticals, Inc. (138.26M), less than Cullinan Oncology, Inc. (630.54M), greater than Mersana Therapeutics, Inc. (204.64M), less than Relay Therapeutics, Inc. (692.53M), less than Arcus Biosciences, Inc. (1.20B), less than Stoke Therapeutics, Inc. (457.69M), greater than Kezar Life Sciences, Inc. (36.78M), less than Phathom Pharmaceuticals, Inc. (480.38M), less than Replimune Group, Inc. (984.10M), less than Chinook Therapeutics, Inc. (2.63B), less than DICE Therapeutics, Inc. (1.82B), less than Pliant Therapeutics, Inc. (770.48M), less than Crinetics Pharmaceuticals, Inc. (4.93B), less than Ascendis Pharma A/S (7.61B),
Company | Enterprise Value | Market cap |
---|---|---|
915.81M | $794.69M | |
166.37M | $147.26M | |
2.52B | $2.61B | |
12.11B | $10.91B | |
963.46M | $1.38B | |
202.73M | $180.51M | |
229.32M | $230.19M | |
1.24B | $1.37B | |
2.65B | $2.77B | |
138.26M | $181.50M | |
630.54M | $730.17M | |
204.64M | $252.01M | |
692.53M | $795.07M | |
1.20B | $1.35B | |
457.69M | $605.41M | |
36.78M | $54.72M | |
480.38M | $638.64M | |
984.10M | $1.02B | |
2.63B | $2.71B | |
1.82B | $2.27B | |
770.48M | $789.88M | |
4.93B | $5.20B | |
7.61B | $7.76B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 2seventy bio, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like 2seventy bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is 2seventy bio, Inc.'s Enterprise Value?
What is the highest Enterprise Value for 2seventy bio, Inc. (TSVT)?
What is the 3-year average Enterprise Value for 2seventy bio, Inc. (TSVT)?
What is the 5-year average Enterprise Value for 2seventy bio, Inc. (TSVT)?
How does the current Enterprise Value for 2seventy bio, Inc. (TSVT) compare to its historical average?